Pubertal Timing, Brain Development And Mental Health In Adolescence
Funder
National Health and Medical Research Council
Funding Amount
$786,976.00
Summary
Early timing of puberty is known to be associated with future mental health problems. This study aims to investigate whether children who go through adrenarche (an earlier phase of maturation) early are at risk for poor mental health during adolescence, and whether abnormal brain development is responsible for linking early adrenarche and mental health outcomes. The results of this research will have implications for the early detection of children at risk for mental health problems.
The Second Australian Study Of Health And Relationships
Funder
National Health and Medical Research Council
Funding Amount
$1,637,477.00
Summary
The present proposal is for the Second Australian Study of Health and Relationships, a survey of 20,000 Australians aged 16–69, in 2011–12 in order to understand and document the changes in Australian sexual behaviour over the past decade. It is essential that policy and practice in the arena of sexual and reproductive health be evidence-based and that the evidence base be as current as is practicable.
Tailoring A Brief Sleep Intervention For Autism: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$401,475.00
Summary
Up to 86% of children with Autism Spectrum Disorder (ASD) experience behavioural sleep problems which have been shown to be associated with increased core ASD symptoms, increased rates of internalizing and externalizing disorders, and increased parental stress. The “Sleeping Sound” study is a novel behavioural sleep intervention that has shown much promise as a treatment to reduce sleep problems and improve mental health outcomes in children with ASD.
Ryanodine Receptor Inhibitors As Therapy For Ca2+ Store Overload Induced Arrhythmias
Funder
National Health and Medical Research Council
Funding Amount
$555,892.00
Summary
This study investigates a new therapeutic action recently discovered for flecainide, an antiarrhythmic agent that we find to completely prevent and inherited form of stress-induced arrhythmias called CPVT. The findings will provide the first detailed mechanistic understanding of an antiarrhythmic drug, findings that will also give a new direction for drug design to control common arrhythmias such as occur in diseases such as coronary artery disease.
Social Functioning In Early Primary School Following Traumatic Brain Injury Prior To Age Three: The Contribution Of Cognitive, Environmental And Neurological Factors
Funder
National Health and Medical Research Council
Funding Amount
$394,501.00
Summary
Children of preschool age and older demonstrate social problems after a traumatic brain injury (TBI). What effect a TBI has on the social function of young children (before 3 years) is currently unknown but is thought that these children have more problems than older children do. This study will look at how a TBI impacts on the social function of young children and the role of cognition and brain development in social function will also be explored.
Effect Of An Interactive Therapeutic Robotic Animal On Engagement, Mood States, Agitation And Antipsychotic Drug Use In People With Dementia: A Cluster Randomized Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,144,641.00
Summary
This study aims to reduce the impact of dementia symptoms and burden on the person with dementia, family and care staff, as well as potentially reducing pharmaceutical usage through an engaging activity using a robotic animal called PARO.
Use Of Analgesics To Reduce Agitation And Agression In Older Persons With Dementia
Funder
National Health and Medical Research Council
Funding Amount
$552,556.00
Summary
Understanding the causes of Behavioural and Psychological Symptoms of Dementia (BPSD) provides a potentially remedial target for interventions. The current study will undertake the first ever trial of analgesics to reduce the frequency of agitation/aggression and other BPSD. By completion we will have new insights into the relationship between pain and various sub-types of BPSD and robust evidence on the best class of analgesics to treat BPSD
Effect Of High Dose Infant Fish Oil Supplementation And FADS 1 & 2 Genetic Polymorphisms On Cognitive Development And School Giftedness
Funder
National Health and Medical Research Council
Funding Amount
$325,938.00
Summary
This project will investigate the influence of fish oil supplementation during the first six months of life on intelligence, language, behaviour and school performance at age six. We will also investigate how genetic differences in fish oil metabolism can impact upon these relationships. The findings will enhance our knowledge pertaining to the potential benefits of fish oil on cognitive development, and will inform future practice regarding the high dose fortification of infant formula.
Characterization Of A Novel Epigenetic Boundary And Long Range Epigenetic Modifications Specific To FMR1 Expansion Carriers With Behavioural And Cognitive Disorders - Implications For Earlier Diagnosis And Treatment.
Funder
National Health and Medical Research Council
Funding Amount
$670,836.00
Summary
Fragile X Syndrome (FXS) is the most common form of inherited intellectual disability and autism and is caused by a faulty switch in the gene FMR1. We have discovered new DNA regions important in FXS. The project aims to explain how these new regions regulate the FMR1 gene. This is essential for the discovery and validation of new avenues for earlier diagnosis, treatments and therapies for children and adults with FMR1 disorders and also for informing reproductive decisions.
Prevention Of Adverse Child Behavioural Development Following Maternal Depression In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$761,937.00
Summary
There is good evidence that if a woman is depressed while pregnant, her child is substantially more likely to have later emotional or behavioural problems. We will evaluate whether child outcomes following maternal depression in pregnancy can be improved by antenatal depression treatment. Our objective is to protect fetal and child development from the adverse developmental outcomes associated with untreated depression.